Evolus (EOLS) Equity Average (2018 - 2026)
Evolus (EOLS) reported Equity Average of -$25.9 million for Q1 2026, down 4695.47% on a YoY basis from $564544.9 in Q1 2025, and little changed quarter-over-quarter from -$25.9 million in Q4 2025.
Evolus (EOLS) Equity Average (2018 - 2026) Analysis & Trends
Evolus has reported Equity Average for 9 years, with the latest figure at -$25.9 million in Q1 2026.
- For the quarter ending Q1 2026, Equity Average fell 4695.47% year-over-year to -$25.9 million; the trailing twelve-month figure through Mar 2026 stood at -$25.9 million (down 4695.47% YoY), and the FY2025 full-year result was -$8.8 million, down 15.94% from the prior year.
- Equity Average for Q1 2026 stood at -$25.9 million, roughly flat from -$25.9 million in the prior quarter.
- The five-year high for Equity Average was $74.6 million in Q1 2022, with the low at -$25.9 million in Q1 2026.
- Historically, Equity Average has averaged $7.1 million across 5 years, with a median of -$7000.0 in 2023.
- Annual changes were most pronounced in 2024 — Equity Average soared 269792.86% — and 2026, when it sank 4695.47%.
- Evolus' Equity Average stood at $23.9 million in 2022, then tumbled by 183.94% to -$20.0 million in 2023, then soared by 128.49% to $5.7 million in 2024, then plunged by 554.49% to -$25.9 million in 2025, then fell by 0.04% to -$25.9 million in 2026.
- The last three Equity Average figures came in at -$25.9 million (Q1 2026), -$25.9 million (Q4 2025), and -$23.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.07 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 3.32 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 6.50 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 409.63 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 3.33 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.52 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.79 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 493.55 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.15 Bn |
| 10 | Evolus | 437.40 Mn | 387.61 Mn | 48.90 Mn | -25.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.94 Mn |
| Dec 31, 2025 | -25.93 Mn |
| Sep 30, 2025 | -23.71 Mn |
| Jun 30, 2025 | -12.63 Mn |
| Mar 31, 2025 | -541,000.00 |
| Dec 31, 2024 | 5.71 Mn |
| Sep 30, 2024 | 12.60 Mn |
| Jun 30, 2024 | 18.88 Mn |
| Mar 31, 2024 | -1.12 Mn |
| Dec 31, 2023 | -20.03 Mn |
| Sep 30, 2023 | -13.17 Mn |
| Jun 30, 2023 | -7,000.00 |
| Mar 31, 2023 | 12.72 Mn |
| Dec 31, 2022 | 23.86 Mn |
| Sep 30, 2022 | 38.04 Mn |
| Jun 30, 2022 | 57.05 Mn |
| Mar 31, 2022 | 74.56 Mn |
| Dec 31, 2021 | 89.64 Mn |
| Sep 30, 2021 | 101.77 Mn |
| Jun 30, 2021 | 64.71 Mn |